History of Generic Medications

In 1983, a team of New York legislators tried to save buyers income by altering the prescription forms applied by doctors. Under their proposition, sick people in New York would get a generic medication from chemists unless the health care professional administered a brand-name drug and penned "administer as written" on the type. A prescription medicine commercialized under its generic brand can price half the price of the equal medication traded under a brand name—the brand given it by the corporation that held the original patent of invention.

3 of America's most prominent pharmaceutical companies —American Home goods, mailed key New York legislators a "Memorandum in Confrontation." It sported aerial pics of two fresh "major pharmaceutical producers" acted against a first floor photo of "a New York City generic producer." The latter centered on a garbage-strewn building site. "We'd apprize your counterpointing their facilities," the memo stated, "and issue whether you believe they can uniformly generate identical medication products."

That was the opening salvo in yet additional round of a long war engaged by the manufacturers of brand-name medications against the generic medication firms that finish with them. The brand-name corporations dominate a prescription medicine market worth $25 billion a yr as of 1987. They shelling legislators, doctors, chemists, and buyers with an unrelenting message: Generic medications are low in quality and could hurt you. Few distortions in the account of commercial message propaganda have cost buyers more money than that one.